Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy
Clinical trial NCT00571168 · UNKNOWN
Trial details
- NCT number
- NCT00571168
- Sponsor
- Heidelberg University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2010-12-01
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.